NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tagworks Pharmaceuticals

Tagworks Pharmaceuticals

Private
NijmegenHealthcare & Life Scienceshttps://www.tagworkspharma.com/

Last Round

Series A

Jun 22, 2023

Total Funding Raised

$74M

Company Overview

Tagworks Pharmaceuticals is a biotechnology company that develops precision oncology treatments using its proprietary Click-to-Release technology to enable controlled drug release in the tumor microenvironment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

click-to-releaseclick chemistryantibody-drug conjugatesADCradiopharmaceuticalsprecision oncologybio-orthogonal chemistrytargeted cancer therapydrug delivery platformbiotech startupclinical-stage biotechsolid tumor treatmenttherapeutic indexnext-gen oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tagworks Pharmaceuticals Comparables

Compare Tagworks Pharmaceuticals with similar companies based on industry and business-model similarity.

Tagworks Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shasqi
86%
Byondis
81%
Adcendo
80%

Tagworks Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2023
SeedNov 27, 2021

Tagworks Pharmaceuticals Investors

Notable investors and investment history

Tagworks Pharmaceuticals investors
InvestorRounds
BIF PartnersSeed, Series A
New Enterprise Associates (NEA)Series A
Lightstone VenturesSeries A
Ysios CapitalSeries A
Gilde HealthcareSeries A
MeneldorSeries A, Seed
Oost NLSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2025

    CSO to present on ADC platform at R&D Symposium on Antibody Conjugates.

  • Apr 23, 2025

    Keith Orford, MD, PhD, appointed as new CMO.

Tagworks Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tagworks Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tagworks Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen
Employee Range47
Year Founded2011
Last FundingJun 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.